These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28418988)

  • 1. HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection.
    Casetti R; Pinnetti C; Sacchi A; De Simone G; Bordoni V; Cimini E; Tumino N; Besi F; Viola D; Turchi F; Mazzotta V; Antinori A; Martini F; Ammassari A; Agrati C
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):338-344. PubMed ID: 28418988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection.
    Pallikkuth S; Fischl MA; Pahwa S
    J Infect Dis; 2013 Nov; 208(10):1613-23. PubMed ID: 23922374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study.
    Bordoni V; Brando B; Piselli P; Forini O; Perna FE; Atripaldi U; Carputo S; Garziano F; Trento E; D'Agosto G; Latini A; Colafigli M; Cristaudo A; Sacchi A; Andreoni M; De Carli G; Orchi N; Grelli S; Gatti A; Cerva C; Minutolo A; Potestà M; Di Martino ML; Ortu F; Selva P; Del Pup L; Guarnori I; Lorenzini P; Capuano G; Antinori A; Agrati C
    PLoS One; 2019; 14(12):e0225415. PubMed ID: 31869342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Human Immunodeficiency Virus primary infection, early combined antiretroviral therapy reduced γδ T-cell activation but failed to restore their polyfunctionality.
    Casetti R; Sacchi A; Bordoni V; Grassi G; Cimini E; Besi F; Pinnetti C; Mondi A; Antinori A; Agrati C
    Immunology; 2019 Aug; 157(4):322-330. PubMed ID: 31206171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype, Polyfunctionality, and Antiviral Activity of
    Salido J; Ruiz MJ; Trifone C; Figueroa MI; Caruso MP; Gherardi MM; Sued O; Salomón H; Laufer N; Ghiglione Y; Turk G
    Front Immunol; 2018; 9():2443. PubMed ID: 30405632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
    Al-Harthi L; Siegel J; Spritzler J; Pottage J; Agnoli M; Landay A
    AIDS; 2000 May; 14(7):761-70. PubMed ID: 10839583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment.
    Kvale D; Ormaasen V; Kran AM; Johansson CC; Aukrust P; Aandahl EM; Frøland SS; Taskén K
    AIDS; 2006 Apr; 20(6):813-20. PubMed ID: 16549964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals.
    Stapleton JT; Chaloner K; Martenson JA; Zhang J; Klinzman D; Xiang J; Sauter W; Desai SN; Landay A
    PLoS One; 2012; 7(11):e50563. PubMed ID: 23209780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression.
    Graw F; Regoes RR
    J Virol; 2014 Sep; 88(17):10134-45. PubMed ID: 24965450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological recovery failure in cART-treated HIV-positive patients is associated with reduced thymic output and RTE CD4+ T cell death by pyroptosis.
    Carvalho-Silva WHV; Andrade-Santos JL; Souto FO; Coelho AVC; Crovella S; Guimarães RL
    J Leukoc Biol; 2020 Jan; 107(1):85-94. PubMed ID: 31691351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Tat immunity defines CD4
    Tripiciano A; Picconi O; Moretti S; Sgadari C; Cafaro A; Francavilla V; Arancio A; Paniccia G; Campagna M; Pavone-Cossut MR; Sighinolfi L; Latini A; Mercurio VS; Pietro MD; Castelli F; Saracino A; Mussini C; Perri GD; Galli M; Nozza S; Ensoli F; Monini P; Ensoli B
    EBioMedicine; 2021 Apr; 66():103306. PubMed ID: 33839064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
    Kolber MA
    AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
    Oxenius A; Price DA; Dawson SJ; Günthard HF; Fischer M; Perrin L; Ramirez E; Fagard C; Hirschel B; Scullard G; Weber JN; McLean AR; Phillips RE;
    AIDS; 2002 Nov; 16(17):2317-22. PubMed ID: 12441804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.
    Nakanjako D; Ssinabulya I; Nabatanzi R; Bayigga L; Kiragga A; Joloba M; Kaleebu P; Kambugu AD; Kamya MR; Sekaly R; Elliott A; Mayanja-Kizza H
    Trop Med Int Health; 2015 Mar; 20(3):380-90. PubMed ID: 25441397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
    Evans TG; Bonnez W; Soucier HR; Fitzgerald T; Gibbons DC; Reichman RC
    Antiviral Res; 1998 Oct; 39(3):163-73. PubMed ID: 9833957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
    D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
    J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of the CD8
    Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
    Front Immunol; 2021; 12():687296. PubMed ID: 34177939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.